These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37331996)

  • 1. Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
    Kong J; Xu S; Zhang P; Wang Y
    Int J Toxicol; 2023; 42(5):420-429. PubMed ID: 37331996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
    Tian J; Lin Y; Yu J
    Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUSAP1, a novel stemness-related protein, promotes early recurrence of hepatocellular carcinoma.
    Li J; Tang M; Wu J; Qu H; Tu M; Pan Z; Gao C; Yang Y; Qu C; Huang W; Hong J
    Cancer Sci; 2022 Dec; 113(12):4165-4180. PubMed ID: 36106345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.
    Roy S; Hooiveld GJ; Seehawer M; Caruso S; Heinzmann F; Schneider AT; Frank AK; Cardenas DV; Sonntag R; Luedde M; Trautwein C; Stein I; Pikarsky E; Loosen S; Tacke F; Ringelhan M; Avsaroglu SK; Goga A; Buendia MA; Vucur M; Heikenwalder M; Zucman-Rossi J; Zender L; Roderburg C; Luedde T
    Gastroenterology; 2018 Dec; 155(6):1951-1966.e26. PubMed ID: 30165047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
    Deng Q; Wang Q; Zong WY; Zheng DL; Wen YX; Wang KS; Teng XM; Zhang X; Huang J; Han ZG
    Cancer Res; 2010 Jan; 70(2):782-91. PubMed ID: 20068156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
    Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
    Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.
    Lin X; Chen J; Li X; Chen D; Luo K; Deng Y; Yang D; Huang Z; Tao C
    Arch Toxicol; 2023 Jun; 97(6):1627-1647. PubMed ID: 37120773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor E2F8 Activates PDK1-Mediated DNA Damage Repair to Enhance Cisplatin Resistance in Lung Adenocarcinoma.
    Li H; Sun J; Hu H; Wang Y
    Pharmacology; 2024; 109(6):341-356. PubMed ID: 38810606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2f8 mediates tumor suppression in postnatal liver development.
    Kent LN; Rakijas JB; Pandit SK; Westendorp B; Chen HZ; Huntington JT; Tang X; Bae S; Srivastava A; Senapati S; Koivisto C; Martin CK; Cuitino MC; Perez M; Clouse JM; Chokshi V; Shinde N; Kladney R; Sun D; Perez-Castro A; Matondo RB; Nantasanti S; Mokry M; Huang K; Machiraju R; Fernandez S; Rosol TJ; Coppola V; Pohar KS; Pipas JM; Schmidt CR; de Bruin A; Leone G
    J Clin Invest; 2016 Aug; 126(8):2955-69. PubMed ID: 27454291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUSAP1 regulates basal cell carcinoma migration, invasion and DNA damage through activation of the Hedgehog signaling pathway.
    Zhu Y; Liu Y; Zhang L; Zeng S; Xu W
    Physiol Int; 2023 Jun; 110(2):160-172. PubMed ID: 37200136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
    Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
    J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of nucleolar and spindle-associated protein 1 expression suppresses liver cancer cell function.
    Wang Y; Ju L; Xiao F; Liu H; Luo X; Chen L; Lu Z; Bian Z
    Exp Ther Med; 2019 Apr; 17(4):2969-2978. PubMed ID: 30936967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway.
    Lin Q
    Cytokine; 2022 Aug; 156():155922. PubMed ID: 35660716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51.
    Han Y; Hu X; Yun X; Liu J; Yang J; Tian Z; Zhang X; Zhang Y; Wang X
    Cell Death Dis; 2021 Nov; 12(11):1083. PubMed ID: 34782617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression.
    Zhang X; Pan Y; Fu H; Zhang J
    Med Sci Monit; 2018 Nov; 24():8553-8564. PubMed ID: 30476929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
    Ding H; Liu J; Zou R; Cheng P; Su Y
    J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway.
    Zhou Y; Tang W; Zhuo H; Zhu D; Rong D; Sun J; Song J
    Bioengineered; 2022 Mar; 13(3):4786-4797. PubMed ID: 35139763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
    Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
    Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.